UPCC 15518 / ANAM-17-21: A Phase 3 Randomized Double-Blind Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
UPCC 15518 / ANAM-17-21: A Phase 3 Randomized Double-Blind Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Recruiting
18-99 years
All
Phase 3
Simplified description (AI rewritten)
Technical description (Original)
The loss of enjoyment of food and weight loss has shown to decrease the quality of life for cancer patients. Additionally, poor eating and weight loss affects patients’ overall health, making them increasingly tired and more likely to experience side effects from their cancer treatments. Some patients have to take lower doses of cancer-fighting treatments or stop using them altogether.
Anamorelin HCl, works by mimicking a naturally occurring substance in the body that causes increased appetite and weight gain.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
Enable functional cookies in order to access shared annotations.
The passcode will expire in None.
Loading...
No annotations made yet
Add a private note
Select a piece of text from the left.
Add notes visible only to you.
Send it to people through a passcode protected link.
Send Notes
Loading...
Publish Annotation
Are you sure you want to publish the annotation?
Delete
Are you sure you want to delete the ?
FAQs
Learn more about clinical trials
What is a clinical trial?
A clinical trial is a study designed to test specific
interventions or treatments' effectiveness and safety,
paving the way for new, innovative healthcare solutions.
Why should I take part in a clinical trial?
Participating in a clinical trial provides early access to
potentially effective treatments and directly contributes to
the healthcare advancements that benefit us all.
How long does a clinical trial take place?
The duration of clinical trials varies. Some trials last
weeks, some years, depending on the phase and intention of
the trial.
Do I get compensated for taking part in clinical
trials?
Compensation varies per trial. Some offer payment or
reimbursement for time and travel, while others may not.
How safe are clinical trials?
Clinical trials follow strict ethical guidelines and
protocols to safeguard participants' health. They are
closely monitored and safety reviewed regularly.